• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孟鲁司特的认知效应:一项药物脑电图研究。

Cognitive Effects of Montelukast: A Pharmaco-EEG Study.

作者信息

Schwimmbeck Fabian, Staffen Wolfgang, Höhn Christopher, Rossini Fabio, Renz Nora, Lobendanz Markus, Reichenpfader Peter, Iglseder Bernhard, Aigner Ludwig, Trinka Eugen, Höller Yvonne

机构信息

Department of Neurology, Christian Doppler University Hospital, Paracelsus Medical University, 5020 Salzburg, Austria.

Centre for Cognitive Neuroscience (CCNS), Department of Psychology, University of Salzburg, 5020 Salzburg, Austria.

出版信息

Brain Sci. 2021 Apr 27;11(5):547. doi: 10.3390/brainsci11050547.

DOI:10.3390/brainsci11050547
PMID:33925326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8145277/
Abstract

Montelukast is a well-established antiasthmatic drug with little side effects. It is a leukotriene receptor antagonist and recent research suggests cognitive benefits from its anti-inflammatory actions on the central nervous system. However, changes in brain activity were not directly shown so far in humans. This study aims to document changes in brain activity that are associated with cognitive improvement during treatment with Montelukast. We recorded EEG and conducted neuropsychological tests in 12 asthma-patients aged 38-73 years before and after 8 weeks of treatment with Montelukast. We found no significant changes on neuropsychological scales for memory, attention, and mood. In the EEG, we found decreased entropy at follow up during rest ( < 0.005). During episodic memory acquisition we found decreased entropy ( < 0.01) and acceleration of the background rhythm ( < 0.05). During visual attention performance, we detected an increase in gamma power ( < 0.005) and slowing of the background rhythm ( < 0.05). The study is limited by its small sample size, young age and absence of baseline cognitive impairment of the participants. Unspecific changes in brain activity were not accompanied by cognitive improvement. Future studies should examine elderly patients with cognitive impairment in a double-blind study with longer-term treatment by Montelukast.

摘要

孟鲁司特是一种成熟的抗哮喘药物,副作用较小。它是一种白三烯受体拮抗剂,最近的研究表明,其对中枢神经系统的抗炎作用具有认知益处。然而,迄今为止,尚未在人类中直接显示出大脑活动的变化。本研究旨在记录孟鲁司特治疗期间与认知改善相关的大脑活动变化。我们对12名年龄在38 - 73岁的哮喘患者在接受孟鲁司特治疗8周前后进行了脑电图(EEG)记录并开展了神经心理学测试。我们发现,在记忆、注意力和情绪的神经心理学量表上没有显著变化。在脑电图方面,我们发现随访时静息状态下熵值降低(<0.005)。在情景记忆获取过程中,我们发现熵值降低(<0.01)且背景节律加快(<0.05)。在视觉注意力表现过程中,我们检测到γ波功率增加(<0.005)且背景节律减慢(<0.05)。该研究受样本量小、参与者年龄轻以及缺乏基线认知障碍的限制。大脑活动的非特异性变化并未伴随认知改善。未来的研究应以双盲研究的方式,对患有认知障碍的老年患者进行更长时间的孟鲁司特治疗研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94d7/8145277/4e23a174b6d0/brainsci-11-00547-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94d7/8145277/04d22dcf0f0d/brainsci-11-00547-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94d7/8145277/44b4f46a7415/brainsci-11-00547-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94d7/8145277/24c21b631112/brainsci-11-00547-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94d7/8145277/044e0ca96ecc/brainsci-11-00547-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94d7/8145277/4e23a174b6d0/brainsci-11-00547-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94d7/8145277/04d22dcf0f0d/brainsci-11-00547-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94d7/8145277/44b4f46a7415/brainsci-11-00547-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94d7/8145277/24c21b631112/brainsci-11-00547-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94d7/8145277/044e0ca96ecc/brainsci-11-00547-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94d7/8145277/4e23a174b6d0/brainsci-11-00547-g005.jpg

相似文献

1
Cognitive Effects of Montelukast: A Pharmaco-EEG Study.孟鲁司特的认知效应:一项药物脑电图研究。
Brain Sci. 2021 Apr 27;11(5):547. doi: 10.3390/brainsci11050547.
2
Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.孟鲁司特,一种白三烯受体拮抗剂,用于治疗2至5岁儿童的持续性哮喘。
Pediatrics. 2001 Sep;108(3):E48. doi: 10.1542/peds.108.3.e48.
3
Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.白三烯受体拮抗剂在患有囊性纤维化肺病儿童中的应用:抗炎作用及临床疗效
Paediatr Drugs. 2005;7(6):353-63. doi: 10.2165/00148581-200507060-00004.
4
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.白三烯拮抗剂孟鲁司特对阿司匹林不耐受性哮喘的改善作用:一项随机、双盲、安慰剂对照试验
Am J Respir Crit Care Med. 2002 Jan 1;165(1):9-14. doi: 10.1164/ajrccm.165.1.2010080.
5
Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.孟鲁司特,一种每日一次的白三烯受体拮抗剂,用于治疗慢性哮喘:一项多中心、随机、双盲试验。孟鲁司特临床研究组。
Arch Intern Med. 1998 Jun 8;158(11):1213-20. doi: 10.1001/archinte.158.11.1213.
6
Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.孟鲁司特,一种白三烯受体拮抗剂,与氯雷他定,一种组胺受体拮抗剂联合使用,用于治疗慢性哮喘。
Arch Intern Med. 2000 Sep 11;160(16):2481-8. doi: 10.1001/archinte.160.16.2481.
7
Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.口服孟鲁司特钠和吸入布地奈德对成人及6岁及以上儿童的长期哮喘控制。
Clin Exp Allergy. 2001 Jun;31(6):845-54. doi: 10.1046/j.1365-2222.2001.01085.x.
8
Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.孟鲁司特,一种白三烯受体拮抗剂,用于治疗轻度哮喘和运动性支气管收缩。
N Engl J Med. 1998 Jul 16;339(3):147-52. doi: 10.1056/NEJM199807163390302.
9
Airway mechanics after withdrawal of a leukotriene receptor antagonist in children with mild persistent asthma: Double-blind, randomized, cross-over study.气道力学在儿童轻度持续性哮喘中白三烯受体拮抗剂停药后的变化:双盲、随机、交叉研究。
Pediatr Pulmonol. 2020 Dec;55(12):3279-3286. doi: 10.1002/ppul.25085. Epub 2020 Sep 29.
10
The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.半胱氨酰白三烯受体拮抗剂孟鲁司特(MK-0476)对变应原诱发的哮喘气道反应及痰液细胞计数的影响
Clin Exp Allergy. 1999 Jan;29(1):42-51. doi: 10.1046/j.1365-2222.1999.00447.x.

引用本文的文献

1
Computational Investigation of Montelukast and Its Structural Derivatives for Binding Affinity to Dopaminergic and Serotonergic Receptors: Insights from a Comprehensive Molecular Simulation.孟鲁司特及其结构衍生物与多巴胺能和5-羟色胺能受体结合亲和力的计算研究:综合分子模拟的见解
Pharmaceuticals (Basel). 2025 Apr 10;18(4):559. doi: 10.3390/ph18040559.
2
The Impact of Montelukast Duration on the Risk of Neuropsychiatric Disorders in Children with Asthma: A Population-Based Cohort Study.孟鲁司特使用时长对哮喘儿童神经精神疾病风险的影响:一项基于人群的队列研究。
Pharmaceuticals (Basel). 2025 Mar 7;18(3):379. doi: 10.3390/ph18030379.
3

本文引用的文献

1
The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice.白三烯受体拮抗剂孟鲁司特减轻转 5xFAD 小鼠的神经炎症并影响认知功能。
Int J Mol Sci. 2021 Mar 9;22(5):2782. doi: 10.3390/ijms22052782.
2
A possible effect of montelukast on neurological aging examined by the use of register data.使用登记数据研究孟鲁司特对神经老化的可能影响。
Int J Clin Pharm. 2021 Jun;43(3):541-548. doi: 10.1007/s11096-020-01160-8. Epub 2020 Oct 9.
3
Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer's Disease mice.
Montelukast Ameliorates 2K1C-Hypertension Induced Endothelial Dysfunction and Associated Vascular Dementia.
孟鲁司特可改善 2K1C 高血压引起的血管内皮功能障碍和相关血管性痴呆。
Curr Hypertens Rev. 2024;20(1):23-35. doi: 10.2174/0115734021276985231204092425.
4
Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series.白三烯受体拮抗剂与儿童、青少年和年轻成人神经精神事件风险:一项自身对照病例系列研究。
Eur Respir J. 2022 Nov 3;60(5). doi: 10.1183/13993003.02467-2021. Print 2022 Nov.
小胶质细胞耗竭可减少阿尔茨海默病小鼠大脑中白三烯通路的关键成分。
Acta Neuropathol Commun. 2020 Aug 8;8(1):129. doi: 10.1186/s40478-020-00989-4.
4
Quantitative EEG as a biomarker in mild cognitive impairment with Lewy bodies.定量脑电图作为路易体轻度认知障碍的生物标志物。
Alzheimers Res Ther. 2020 Jul 8;12(1):82. doi: 10.1186/s13195-020-00650-1.
5
A virtual reality paradigm to assess episodic memory: Validation-dataset for six parallel versions and a structured behavioral assessment.一种评估情景记忆的虚拟现实范式:六个并行版本的验证数据集及结构化行为评估
Data Brief. 2020 Feb 13;29:105279. doi: 10.1016/j.dib.2020.105279. eCollection 2020 Apr.
6
The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies.白三烯受体拮抗剂孟鲁司特可减少路易体痴呆动物模型中的α-突触核蛋白负荷并恢复记忆。
Neurotherapeutics. 2020 Jul;17(3):1061-1074. doi: 10.1007/s13311-020-00836-3.
7
Ageing as a risk factor for neurodegenerative disease.衰老作为神经退行性疾病的一个风险因素。
Nat Rev Neurol. 2019 Oct;15(10):565-581. doi: 10.1038/s41582-019-0244-7. Epub 2019 Sep 9.
8
Improvement of fiber connectivity and functional recovery after stroke by montelukast, an available and safe anti-asthmatic drug.孟鲁司特,一种现有的安全的哮喘药物,可改善中风后的纤维连接和功能恢复。
Pharmacol Res. 2019 Apr;142:223-236. doi: 10.1016/j.phrs.2019.02.025. Epub 2019 Feb 25.
9
Recalibrating the Relevance of Adult Neurogenesis.重新校准成人神经发生的相关性。
Trends Neurosci. 2019 Mar;42(3):164-178. doi: 10.1016/j.tins.2018.12.001. Epub 2019 Jan 24.
10
The leukotriene signaling pathway: a druggable target in Alzheimer's disease.白三烯信号通路:阿尔茨海默病的一个可药物治疗靶点。
Drug Discov Today. 2019 Feb;24(2):505-516. doi: 10.1016/j.drudis.2018.09.008. Epub 2018 Sep 18.